La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Firebrick Pharma Gestion
Gestion contrôle des critères 3/4
Firebrick Pharma's CEO is Peter Molloy, appointed in Apr 2012, has a tenure of 12.33 years. total yearly compensation is A$351.30K, comprised of 80.7% salary and 19.3% bonuses, including company stock and options. directly owns 16.05% of the company’s shares, worth A$1.76M. The average tenure of the management team and the board of directors is 3.7 years and 8 years respectively.
Informations clés
Peter Molloy
Directeur général
AU$351.3k
Rémunération totale
| Pourcentage du salaire du PDG | 80.7% |
| Durée du mandat du directeur général | 12.3yrs |
| Propriété du PDG | 16.1% |
| Durée moyenne d'occupation des postes de direction | 3.7yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 8yrs |
Mises à jour récentes de la gestion
Recent updates
Here's Why We're Watching Firebrick Pharma's (ASX:FRE) Cash Burn Situation
Aug 14
We Think Firebrick Pharma (ASX:FRE) Needs To Drive Business Growth Carefully
May 02We Think Firebrick Pharma (ASX:FRE) Needs To Drive Business Growth Carefully
Dec 14Companies Like Firebrick Pharma (ASX:FRE) Are In A Position To Invest In Growth
Aug 30Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -AU$5m |
| Sep 30 2023 | n/a | n/a | -AU$6m |
| Jun 30 2023 | AU$351k | AU$284k | -AU$7m |
| Mar 31 2023 | n/a | n/a | -AU$6m |
| Dec 31 2022 | n/a | n/a | -AU$5m |
| Sep 30 2022 | n/a | n/a | -AU$5m |
| Jun 30 2022 | AU$324k | AU$252k | -AU$4m |
| Mar 31 2022 | n/a | n/a | -AU$3m |
| Dec 31 2021 | n/a | n/a | -AU$3m |
| Sep 30 2021 | n/a | n/a | -AU$3m |
| Jun 30 2021 | AU$140k | AU$140k | -AU$2m |
Rémunération vs marché: Peter's total compensation ($USD235.99K) is about average for companies of similar size in the Australian market ($USD299.11K).
Rémunération et revenus: Peter's compensation has increased whilst the company is unprofitable.
PDG
Peter Molloy (70 yo)
12.3yrs
Titularisation
AU$351,298
Compensation
Dr. Peter Laurence Molloy, BSc, MBA, FAICD is the Founder, Executive Chairman and Chief Executive Officer of Firebrick Pharma Limited since April 12, 2012. He served as Managing Director and Chief Executiv...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Founder | 12.3yrs | AU$351.30k | 16.05% A$ 1.8m | |
| Founder | 12.3yrs | AU$290.56k | 15.8% A$ 1.7m | |
| Chief Financial Officer | 1.7yrs | pas de données | pas de données | |
| Chief Scientific Officer | no data | pas de données | 0.51% A$ 56.0k | |
| Chief Medical Officer | no data | pas de données | pas de données | |
| Head of Regulatory Affairs | 2.7yrs | pas de données | pas de données | |
| Company Secretary | 3.7yrs | pas de données | pas de données |
3.7yrs
Durée moyenne de l'emploi
Gestion expérimentée: FRE's management team is considered experienced (3.7 years average tenure).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Founder | 12.3yrs | AU$351.30k | 16.05% A$ 1.8m | |
| Founder | 12.3yrs | AU$290.56k | 15.8% A$ 1.7m | |
| Independent Non-Executive Director | 3.8yrs | AU$75.00k | 0.31% A$ 33.6k | |
| Non-Executive Director | 2.2yrs | AU$50.00k | pas de données |
8.0yrs
Durée moyenne de l'emploi
Conseil d'administration expérimenté: FRE's board of directors are considered experienced (8 years average tenure).